Published in Neurobiol Aging on March 26, 2007
The use of PET in Alzheimer disease. Nat Rev Neurol (2010) 2.13
Update on the pharmacological treatment of Alzheimer's disease. Curr Neuropharmacol (2010) 1.07
PET radiopharmaceuticals for probing enzymes in the brain. Am J Nucl Med Mol Imaging (2013) 0.89
Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients. Curr Alzheimer Res (2009) 0.86
Acetylcholine esterase activity in mild cognitive impairment and Alzheimer's disease. Eur J Nucl Med Mol Imaging (2008) 0.86
Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development. Alzheimers Res Ther (2011) 0.82
Brain imaging of nicotinic receptors in Alzheimer's disease. Int J Alzheimers Dis (2010) 0.82
Simulations of symptomatic treatments for Alzheimer's disease: computational analysis of pathology and mechanisms of drug action. Alzheimers Res Ther (2012) 0.79
A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease. Prim Care Companion CNS Disord (2013) 0.78
Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PET. Psychopharmacology (Berl) (2008) 0.77
Cholinergic imaging in dementia spectrum disorders. Eur J Nucl Med Mol Imaging (2016) 0.76
PET Imaging of the Human Nicotinic Cholinergic Pathway in Atherosclerosis. Curr Cardiol Rep (2015) 0.76
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
Crystal structure of human carbonic anhydrase C. Nat New Biol (1972) 4.10
Dampness in buildings and health. Nordic interdisciplinary review of the scientific evidence on associations between exposure to "dampness" in buildings and health effects (NORDDAMP). Indoor Air (2001) 2.71
Neuronal nicotinic receptors in the human brain. Prog Neurobiol (2000) 2.31
Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology (1991) 2.05
Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology (1999) 1.78
Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke (2003) 1.78
PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate. J Nucl Med (2000) 1.72
Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis. J Cereb Blood Flow Metab (1989) 1.71
Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport (2001) 1.63
Regional cerebral blood flow and oxygen metabolism during migraine with and without aura. Cephalalgia (1997) 1.61
Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr Cogn Disord (1998) 1.55
Cerebral blood flow in subjects with social phobia during stressful speaking tasks: a PET study. Am J Psychiatry (2001) 1.52
Ammonia, a selective agent for methane production by syntrophic acetate oxidation at mesophilic temperature. Water Sci Technol (2008) 1.52
Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease. Neurobiol Aging (2000) 1.49
Microwave-supported preparation of (68)Ga bioconjugates with high specific radioactivity. Bioconjug Chem (2004) 1.47
Aluminosis and dementia. Lancet (1994) 1.43
Treatment of Alzheimer disease with tacrine: a cost-analysis model. Alzheimer Dis Assoc Disord (1997) 1.42
Collection of airborne micro-organisms on Nuclepore filters, estimation and analysis--CAMNEA method. J Appl Bacteriol (1986) 1.39
Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. Neuroreport (1999) 1.38
[More accurate diagnosis could identify patients suitable for tacrine therapy]. Lakartidningen (1996) 1.37
Structure of satellite tobacco necrosis virus at 3.0 A resolution. J Mol Biol (1982) 1.35
Three-dimensional structure of a specific pre-messenger RNP particle established by electron microscope tomography. Nature (1986) 1.34
Identification of human brain loci processing esophageal sensation using positron emission tomography. Gastroenterology (1997) 1.31
Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months. Neurology (2002) 1.30
Pancreatic neuroendocrine tumors: diagnosis with PET. Radiology (1995) 1.26
No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes. Arch Neurol (1997) 1.25
High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters. Curr Alzheimer Res (2010) 1.23
Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J Neurochem (2000) 1.23
Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET. Biol Psychiatry (1999) 1.21
Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia. J Chem Neuroanat (2001) 1.20
Synthesis of L- and D-[methyl-11C]methionine. J Nucl Med (1987) 1.20
Simultaneous intracerebral microdialysis and positron emission tomography in the detection of ischemia in patients with subarachnoid hemorrhage. J Cereb Blood Flow Metab (1996) 1.18
Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy. Behav Brain Res (1993) 1.17
Purification, crystallization and preliminary X-ray data of the bacteriophage MS2. J Mol Biol (1986) 1.16
Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type. J Neural Transm Park Dis Dement Sect (1993) 1.15
Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation? J Clin Oncol (1995) 1.12
Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). J Neural Transm Park Dis Dement Sect (1992) 1.11
Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels. Neurobiol Aging (2006) 1.11
Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease. Clin Neurophysiol (2000) 1.11
Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dement Geriatr Cogn Disord (2000) 1.10
Middle cerebral artery occlusion and reperfusion in primates monitored by microdialysis and sequential positron emission tomography. Stroke (2001) 1.10
Evaluation of methods for enumerating microorganisms in filter samples from highly contaminated occupational environments. Am Ind Hyg Assoc J (1990) 1.10
Functional neuroanatomical correlates of electrodermal activity: a positron emission tomographic study. Psychophysiology (1998) 1.09
2.2 A resolution structure of the amino-terminal half of HIV-1 reverse transcriptase (fingers and palm subdomains). Structure (1994) 1.09
Brain activation in young and older adults during implicit and explicit retrieval. J Cogn Neurosci (1997) 1.09
Classification of fungi by means of pyrolysis-gas chromatography-pattern recognition. J Chromatogr (1979) 1.08
Postnatal changes of nicotinic acetylcholine receptor alpha 2, alpha 3, alpha 4, alpha 7 and beta 2 subunits genes expression in rat brain. Int J Dev Neurosci (1998) 1.07
Harmonized diagnostic criteria for Alzheimer's disease: recommendations. J Intern Med (2014) 1.07
The preparation of 11C-methyl iodide and its use in the synthesis of 11C-methyl-L-methionine. Int J Appl Radiat Isot (1976) 1.06
Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain. Brain Res Mol Brain Res (1999) 1.06
Osteoarthritis patients' perceptions of "appropriateness" for total joint replacement surgery. Osteoarthritis Cartilage (2012) 1.06
Crystal structure of human erythrocyte carbonic anhydrase C. 3. Molecular structure of the enzyme and of one enzyme-inhibitor complex at 5-5 A resolution. J Mol Biol (1967) 1.05
D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study. Eur Neuropsychopharmacol (2001) 1.05
Safety of lumbar puncture procedures in patients with Alzheimer's disease. Curr Alzheimer Res (2009) 1.05
Word production: dissociation of two retrieval modes of semantic memory across time. J Clin Exp Neuropsychol (1998) 1.04
Identification of volatile metabolites from five fungal species cultivated on two media. Appl Environ Microbiol (1995) 1.04
Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study. Dement Geriatr Cogn Disord (2010) 1.04
The value of human life: an empirical perspective. Econ Inq (1981) 1.04
Studies of signal suppression in liquid chromatography-electrospray ionization mass spectrometry using volatile ion-pairing reagents. J Chromatogr A (2001) 1.03
Mild cognitive impairment: a cross-national comparison. J Neurol Neurosurg Psychiatry (2004) 1.03
First symptoms--frontotemporal dementia versus Alzheimer's disease. Dement Geriatr Cogn Disord (2000) 1.03
Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci Lett (1986) 1.03
Regulation of alpha- and beta-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the alpha-secretase pathway. Biochem Biophys Res Commun (2007) 1.03
PET as a tool in the clinical evaluation of pituitary adenomas. J Nucl Med (1991) 1.03
Effects of occupational exposure to mercury vapour on the central nervous system. Br J Ind Med (1992) 1.03
Manganese induced brain lesions in Macaca fascicularis as revealed by positron emission tomography and magnetic resonance imaging. Arch Toxicol (1992) 1.02
Regional distribution of nicotinic receptors during prenatal development of human brain and spinal cord. Brain Res Dev Brain Res (1998) 1.02
Haemodynamic and metabolic disturbances in the acute stage of subarachnoid haemorrhage demonstrated by PET. Acta Neurol Scand (2004) 1.02
Pharmacokinetics and red cell utilization of iron(III) hydroxide-sucrose complex in anaemic patients: a study using positron emission tomography. Br J Haematol (1999) 1.02
Non-synchronous behavior of neuronal activity, oxidative metabolism and blood supply during mental tasks in man. Neurosci Lett (1994) 1.02
Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients. J Neurochem (2004) 1.02
Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress. Neurobiol Dis (2007) 1.01
Characterization of the human FLICE-inhibitory protein locus and comparison of the anti-apoptotic activity of four different flip isoforms. Scand J Immunol (2001) 1.01
Muscarinic receptors in human SH-SY5Y neuroblastoma cell line: regulation by phorbol ester and retinoic acid-induced differentiation. Brain Res (1987) 1.01
Principal component analysis of dynamic positron emission tomography images. Eur J Nucl Med (1994) 1.01
Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C]methionine. J Comput Assist Tomogr (1983) 1.00
MRI in successful aging, a 5-year follow-up study from the eighth to ninth decade of life. Magn Reson Imaging (1996) 1.00
Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET. Neurology (1996) 1.00
Neuropsychiatric function of housepainters with previous long-term heavy exposure to organic solvents. Scand J Work Environ Health (1995) 0.99
Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment. J Neural Transm (Vienna) (2006) 0.99
Quantitative electroencephalography power and coherence in Alzheimer's disease and mild cognitive impairment. Dementia (1997) 0.98
Development of ligands for in vivo imaging of cerebral nicotinic receptors. Behav Brain Res (2000) 0.98